The Society of Nuclear Medicine recently added the tagline “advancing molecular imaging” to its logo. Now it is developing a center of molecular imaging in an effort to disseminate information and promote research in the rapidly advancing field.
The Society of Nuclear Medicine recently added the tagline "advancing molecular imaging" to its logo. Now it is developing a center of molecular imaging in an effort to disseminate information and promote research in the rapidly advancing field.
Society president Dr. Mathew Thakur, director of radiopharmaceutical research and nuclear medicine research at Thomas Jefferson University, detailed the SNM's intentions in creating such a center in the December issue of the Journal of Nuclear Medicine.
While the center is still virtual at the moment, it is set to go live after the society's midwinter educational symposium next week in Florida. At the meeting, a task force will hammer out operational procedures such as selection of officers and membership dues.
The center will welcome input from everyone interested in molecular imaging, including physicians, scientists, technologists, and radiologists, Thakur said. It will address such molecular imaging topics as surrogate markers, drug development, targeted diagnosis and therapies, and training in these areas.
One avenue the center will use to promote research is development of molecular imaging 101-type courses to be taught at academic institutions and of traveling classes. While these are long-term goals, the center already has two molecular imaging courses prepared for the SNM's annual meeting in June, he said.
The SNM will work with federal organizations such as the National Institute for Biomedical Imaging and Bioengineering to acquire additional funds to promote activities that will support future molecular imaging research.
Thakur noted that the center's activities will be inclusive, also focusing on research in optical imaging, ultrasound, CT, and MRI.
"We are very excited about this project. Molecular imaging has very deep roots in nuclear medicine. This center will have a major role to play in this developing field," he said.
For more information from the online Diagnostic Imaging archives:
SNM Image of the Year signals personalized care
New research body can enhance imaging's future
Molecular imaging complex, elusive, but important topic for radiology
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.